Hematologist-Oncologist, Dr. Michael Friedman Professor in Translational Medicine
1989 - American Board of Internal Medicine, Subspecialty Medical Oncology
1987 - American Board of Internal Medicine
1984 – Ph.D., Tumor Cell Biology, Northwestern University Graduate School, Evanston, IL
1982 – B.S., M.D., Honors Program, Northwestern University Medical School, Chicago, IL
1979 – B.S., Medical Sciences, Northwestern University, Evanston, IL
1987 – 1991, Fellow, Medical Oncology, Stanford University School of Medicine, Stanford, CA
1983 – 1984, Fellow, Tumor Cell Biology, Northwestern University Medical School, Chicago, IL
1985 – 1987, Resident, Internal Medicine, Stanford University Medical Center, Stanford, CA
1984 – 1985, Intern, Internal Medicine, Stanford University Medical Center, Stanford, CA
Larry W. Kwak, M.D., Ph.D., is a world-renowned physician and scientist who has pioneered breakthrough innovations in immunology and cancer vaccines. He joined City of Hope in April 2015, following a decade of leadership in lymphoma and myeloma research and treatment at M.D. Anderson Cancer Center in Houston.
Named one of TIME magazine's "100 Most Influential People" in 2010, Dr. Kwak is the deputy director of City of Hope's comprehensive cancer center, director of the Toni Stephenson Lymphoma Center within the Hematologic Malignancies and Stem Cell Transplantation Institute and is endowed with the title of the Dr. Michael Friedman Professor in Translational Medicine.
Passionate about harnessing the body's immune system to battle cancer, Dr. Kwak's interest in the field was sparked by a high school mentor and has continued for nearly three decades. He takes special pride in his ability to rapidly translate basic research into human clinical trials, making him an ideal fit for the City of Hope environment.